Vertex Pharmaceuticals Inc
NASDAQ:VRTX

Watchlist Manager
Vertex Pharmaceuticals Inc Logo
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Watchlist
Price: 445.21 USD 1.04% Market Closed
Updated: May 18, 2024

Vertex Pharmaceuticals Inc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vertex Pharmaceuticals Inc
Interest Income Expense Peer Comparison

Comparables:
ABBV
GILD
AMGN
MRNA
REGN

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Interest Income Expense
$630.1m
CAGR 3-Years
93%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Interest Income Expense
-$1.8B
CAGR 3-Years
11%
CAGR 5-Years
-6%
CAGR 10-Years
-18%
Gilead Sciences Inc
NASDAQ:GILD
Interest Income Expense
-$663m
CAGR 3-Years
38%
CAGR 5-Years
3%
CAGR 10-Years
-8%
Amgen Inc
NASDAQ:AMGN
Interest Income Expense
-$2.9B
CAGR 3-Years
-44%
CAGR 5-Years
-30%
CAGR 10-Years
-16%
Moderna Inc
NASDAQ:MRNA
Interest Income Expense
$345m
CAGR 3-Years
219%
CAGR 5-Years
65%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Interest Income Expense
$221.8m
CAGR 3-Years
-13%
CAGR 5-Years
75%
CAGR 10-Years
N/A

See Also

What is Vertex Pharmaceuticals Inc's Interest Income Expense?
Interest Income Expense
630.1m USD

Based on the financial report for Mar 31, 2024, Vertex Pharmaceuticals Inc's Interest Income Expense amounts to 630.1m USD.

What is Vertex Pharmaceuticals Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 3Y
93%

Over the last year, the Interest Income Expense growth was 328%. The average annual Interest Income Expense growth rates for Vertex Pharmaceuticals Inc have been 93% over the past three years .